Darren Opland | executive |
Herriot Tabuteau | executive |
Nick Pizzie | executive |
Ari Maizel | executive |
Charles Duncan | analyst |
David Marek | executive |
Leonid Timashev | analyst |
Ashwani Verma | analyst |
Raghuram Selvaraju | analyst |
Marc Goodman | analyst |
David Amsellem | analyst |
Yatin Suneja | analyst |
Jason Gerberry | analyst |
Joon Lee | analyst |
Joel Beatty | analyst |
David Hoang | analyst |
Vikram Purohit | analyst |
Matthew Kaplan | analyst |
Myles Minter | analyst |
Mark Jacobson | executive |
Good morning, and welcome to the Axsome Therapeutics conference call. [Operator Instructions] As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to your host, Darren Opland, Director of Corporate Communications at Axsome Therapeutics. Please go ahead.
Good morning, and thank you all for joining us on today's conference call.